FDA Inspection 1256993 — Greer Laboratories, Inc.

Greer Laboratories, Inc. — FEI 1011574

The FDA completed an inspection of Greer Laboratories, Inc. on Dec 18, 2024 in Lenoir, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 18, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Lenoir, NC (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
121521 CFR 211.67(b)Written procedures not established/followed
136121 CFR 211.100(a)Absence of Written Procedures
143421 CFR 211.42(c)(10)(iv)Environmental Monitoring System
356521 CFR 211.58Buildings not maintained in good state of repair

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.